China $6bn public VC injection a boost for biotech
This article was originally published in Scrip
Executive Summary
China has announced a CNY40bn ($6.5bn) venture capital fund injection to its strategic emerging industries (SEIs), including biotech, potentially a welcome shot in the arm for the burgeoning sector.